Ask AI

CLL Challenge! Interrogating the Latest Evidence on Patient Priorities and Novel Targeted Therapies

Improve your ability to apply biomarker-guided strategies, evaluate emerging evidence for novel targeted and cellular therapies, and individualize treatment selection and sequencing for patients with CLL/SLL while incorporating patient preferences and shared decision-making through an expert-written ClinicalThought commentary and certified on-demand webcast with accompanying downloadable slides.

Share

Program Content

Events

Activities

CLL Challenge Office Hours Forum
CLL Challenge: Expert Office Hours Social Media Forum
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 06, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education in partnership with CLL Society.

Supporters

Supported by educational grants from AstraZeneca, BeOne Medicines, and Lilly.

AstraZeneca

BeOne Medicines

Lilly

Partners

CLL Society

ProCE Banner